Sun Pharma has received a warning letter from the US FDA for manufacturing practice violations at its Dadra unit. This follows an earlier audit and action notice by the US regulator. The ...
US Food and Drug Administration (USFDA) will re-audit three manufacturing facilities of Dr Reddy's Laboratories in the current quarter. The latest USFDA warning letter to Wockhardt for its active ...
The company's topical manufacturing facility at Ahmedabad has received an EIR from the United States Food and Drug Administration (USFDA) signifying the successful closure of the audit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback